Editorial Board
Nicolas Williet PhD
University hospital of saint etienne · France
Editorial leadership for International Journal of Negative Results ISSN 2641-9181
Research interests
- Pancreatic Disease Pancreatic Cancer (Diagnosis
- Treatment) Acute Pancreatitis Chronic Pancreatitis Pancreatic Cystic Lesions Ultrasound Endoscopy Interventionnal Endoscopy (Ercp
- Eus
- Resection Etc...)
Biography
Publications:
- Cytomegalovirus and infl ammatory bowel diseases, with a special focus on its role in ulcerative colitis.
- Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
- Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease.
- Urinary tract infections in hospitalized inflammatory bowel disease patients: A 10-year experience.
- Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study.
- Dietary Beliefs and Behavior Among Inflammatory Bowel Disease Patients.
- Guidelines on the diagnosis and treatment of iron deficiency across indications: A systematic review.
- Distribution of Cytomegalovirus DNA Load in the Inflamed Colon of Ulcerative Colitis Patients.
- Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
- The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: Validation of a surface biomarker.
Selected publications
- Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial 2021 cited 61×
- Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study 2019 cited 47×
- Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study 2024 cited 31×
- Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort 2021 cited 25×
- The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn’s Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation 2020 cited 18×
- Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR) 2024 cited 14×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJNR for your work?
This journal is guided by Nicolas Williet (University hospital of saint etienne) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.